Point of Care (POC) Molecular Diagnostics Market Industry Challenges, Key Vendors, Drivers, Trends and Forecast 2024 : Grand View Research Inc.
San Francisco, 2 April 2019: The Report Point of Care (PoC) Molecular Diagnostics Market Analysis By Application, (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology), By Technology (PCR-based, Microarray-based, Hybridization-based, Genetic Sequencing-based), By Test Location, (Over-the-counter, Point-of-care), By End-use (Decentralized Labs, Hospitals, Home-care, Assisted Living Facilities) And Segment Forecasts To 2024 Global Point of Care (POC) Molecular Diagnostics Market is anticipated to reach USD 3.9 billion by 2024, according to a new report by Grand View Research, Inc. Ongoing research & development to miniaturize molecular diagnostics testing that provides enhanced near patient testing with high accuracy & lesser turnaround times are major factors expected to reinforce the high growth potential for POC MDx products. Growing demand for CLIA tests that are, by definition, portable and safe enough to be used in non-laboratory settings such